✉ Email this page to a colleague
« Back to Dashboard
Antizol is a drug marketed by Par Pharm Inc and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has nine patent family members in eight countries.
The generic ingredient in ANTIZOL is fomepizole. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fomepizole profile page.
A generic version of ANTIZOL was approved as fomepizole by AM REGENT on December 14th, 2007.
Summary for ANTIZOL
Recent Clinical Trials for ANTIZOL
Identify potential brand extensions & 505(b)(2) entrants
|Horizon Pharma USA, Inc.||Phase 2|
|Ted Daley, President||Phase 2|
|Raptor Pharmaceuticals Inc.||Phase 2|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Par Pharm Inc||ANTIZOL||fomepizole||INJECTABLE;INJECTION||020696-001||Dec 4, 1997||DISCN||Yes||No||See Plans and Pricing||See Plans and Pricing||Y||Y||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
See the table below for patents covering ANTIZOL around the world.
|Country||Patent Number||Title||Estimated Expiration|
|China||101163679||Method of preparing ultrapure 4-methylpyrazole||See Plans and Pricing|
|European Patent Office||1948613||PROCEDE POUR LA PREPARATION DE LA 4-METHYLPYRAZOLE ULTRAPURE (PROCESS FOT THE PREPARATION OF ULTRAPURE 4-METHYLPYRAZOLE)||See Plans and Pricing|
|World Intellectual Property Organization (WIPO)||2006115626||See Plans and Pricing|
|Australia||2006240490||Process for the preparation of ultrapure 4-methylprazole||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|